|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.895 EUR | +0.26% |
|
0.00% | +33.02% |
| 06-29 | Sopharma AD Approves Gross Dividend for 2025 | CI |
| 06-22 | Sopharma AD Reports Sales Results for the Month and Year to Date Ended May 2026 | CI |
| Market Cap | 1.9B 1.14B 1B 926M 851M 1.61B 110B 1.63B 11.07B 4.34B 53.9B 4.29B 4.2B 186B | P/E 2024 |
12.3x | P/E 2025 | 7.16x |
|---|---|---|---|---|---|
| Enterprise Value | 2.44B 1.47B 1.29B 1.19B 1.09B 2.06B 142B 2.1B 14.22B 5.57B 69.24B 5.51B 5.39B 239B | EV / Sales 2024 |
0.66x | EV / Sales 2025 | 0.76x |
| Free-Float |
31.06% | Yield 2024 |
2.68% | Yield 2025 | - |
| 1 day | +0.26% | ||
| Current month | -1.81% | ||
| 1 month | -1.81% | ||
| 3 months | +10.17% | ||
| 6 months | -3.32% | ||
| Current year | +33.02% |
| 1 week | 1.85 |  | 1.9 |
| 1 month | 1.85 | | 1.94 |
| Current year | 1.41 | | 2 |
| 1 year | 1.21 | | 2 |
| 3 years | 0.9 | | 2 |
| 5 years | 0.58 | | 2 |
| 10 years | 0.41 | | 2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CEO | Chief Executive Officer | 42 | 01/10/2000 |
Boris Borisov
DFI | Director of Finance/CFO | - | 01/01/2002 |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CHM | Chairman | 42 | 19/05/2010 |
| Director/Board Member | 63 | 19/05/2010 | |
| Director/Board Member | 61 | 12/07/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 9/30/20 A | Donev Investments Ad
| Buy | Company | 25,489 | 0.0189% | |
| 9/30/20 A | Buy | Chief Executive Officer | 12,000 | 0.0089% | ||
| 9/29/20 A | Buy | Chief Executive Officer | 1,000 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.26% | 0.00% | +49.01% | +112.28% | 1.14B | |
| +1.10% | +4.71% | -19.88% | -25.93% | 15.57B | |
| +1.16% | +5.76% | -25.74% | -30.89% | 7.11B | |
| -1.72% | +1.49% | -22.06% | -7.49% | 6.13B | |
| +3.36% | +4.01% | -9.08% | -28.65% | 3.85B | |
| -0.46% | +4.11% | -38.48% | -12.05% | 3.23B | |
| +1.33% | -0.16% | -30.38% | -48.65% | 3.12B | |
| +1.35% | +4.09% | +10.77% | -29.72% | 3.17B | |
| -1.83% | -1.27% | +96.15% | - | 2.52B | |
| +0.64% | +3.55% | -17.85% | -0.86% | 2.56B | |
| Average | +0.52% | +1.38% | -0.75% | -8.00% | 4.84B | |
| Weighted average by Cap. | +0.66% | +2.48% | -12.30% | -20.46% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 1.28B 1.13B 1.04B 957M 1.81B 124B 1.84B 12.45B 4.88B 60.63B 4.83B 4.72B 209B | 2.63B 1.58B 1.39B 1.28B 1.18B 2.22B 152B 2.26B 15.32B 6B 74.6B 5.94B 5.81B 257B |
| Net income | 77.85M 46.75M 40.98M 37.88M 34.84M 65.73M 4.51B 66.79M 453M 178M 2.21B 176M 172M 7.6B | 134M 80.19M 70.29M 64.97M 59.76M 113M 7.73B 115M 777M 305M 3.78B 301M 295M 13.04B |
| Net Debt | 444M 267M 234M 216M 199M 375M 25.73B 381M 2.58B 1.01B 12.59B 1B 980M 43.37B | 541M 325M 285M 263M 242M 457M 31.35B 464M 3.15B 1.23B 15.34B 1.22B 1.19B 52.85B |
Employees
6,005
Sector
Drug Retailers
Calendar
07-30 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | €1.895 | +0.26% | 270 |
| 17/07/26 | €1.890 | +2.16% | 2,681 |
| 16/07/26 | €1.850 | -1.60% | 895 |
| 15/07/26 | €1.880 | 0.00% | 7,079 |
| 14/07/26 | €1.880 | -0.79% | 2,724 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SFA Stock
Select your edition
All financial news and data tailored to specific country editions
